$LBUY
LEAFBUYER TECHNOLOGIES, INC. Stock $lbuy

$lbuy Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000147793223008496 Filed on November 15, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$1.434M	$1.170M	$1.129M
YoY Change	6.89%	3.63%	32.52%
Cost Of Revenue	$985.5K	$813.3K	$652.5K
YoY Change	57.52%	24.65%	3.49%
Gross Profit	$448.7K	$356.3K	$476.1K
YoY Change	-37.52%	-25.17%	115.3%
Gross Profit Margin	31.28%	30.46%	42.19%
Selling, General & Admin	$356.1K	$445.9K	$324.5K
YoY Change	9.75%	37.41%	-14.62%
% of Gross Profit	79.37%	125.15%	68.15%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$182.2K	$180.0K	$181.1K
YoY Change	0.61%	-0.61%	0.0%
% of Gross Profit	40.61%	50.52%	38.04%
Operating Expenses	$645.7K	$717.3K	$635.1K
YoY Change	11.51%	12.93%	-21.55%
Operating Profit	-$197.1K	-$361.0K	-$159.0K
YoY Change	-244.73%	127.06%	-72.98%
Interest Expense	$22.94K	$37.62K	$51.03K
YoY Change	-47.98%	-26.27%	-98.29%
% of Operating Profit
Other Income/Expense, Net	$10.00	$0.00	$50.00
YoY Change	-99.7%	-100.0%
Pretax Income	-$220.0K	-$400.0K	-$210.0K
YoY Change	-10.51%	90.5%	-107.1%
Income Tax
% Of Pretax Income
Net Earnings	-$220.0K	-$398.6K	-$210.0K
YoY Change	-330.63%	89.83%	-107.1%
Net Earnings / Revenue	-15.34%	-34.08%	-18.6%
Basic Earnings Per Share	$0.00	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	-$2.233K
COMMON SHARES
Basic Shares Outstanding	99.43M shares	99.43M shares	94.62M shares
Diluted Shares Outstanding		151.1M shares	145.7M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$226.7K	$200.0K	$225.3K
YoY Change	-23.99%	-11.24%	-60.34%
Cash & Equivalents	$226.7K	$202.9K	$225.3K
Short-Term Investments
Other Short-Term Assets	$16.60K	$20.00K	$14.73K
YoY Change	-31.91%	35.78%	44.7%
Inventory
Prepaid Expenses
Receivables	$145.1K	$127.2K	$26.60K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$388.4K	$345.9K	$266.6K
YoY Change	1.85%	29.71%	-57.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.500K		$1.768M
YoY Change	-99.91%		-29.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets			$0.00
YoY Change
Total Long-Term Assets	$862.8K	$1.044M	$1.768M
YoY Change	-45.64%	-40.97%	-29.06%
TOTAL ASSETS
Total Short-Term Assets	$388.4K	$345.9K	$266.6K
Total Long-Term Assets	$862.8K	$1.044M	$1.768M
Total Assets	$1.251M	$1.390M	$2.035M
YoY Change	-36.44%	-31.71%	-34.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$341.4K	$312.1K	$318.9K
YoY Change	71.75%	-2.14%	-17.38%
Accrued Expenses	$1.093M	$1.089M	$1.055M
YoY Change	16.29%	3.3%	12.85%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.077M	$1.100M	$1.621M
YoY Change	-32.04%	-32.16%	-6.26%
Total Short-Term Liabilities	$2.512M	$2.510M	$3.007M
YoY Change	-7.96%	-16.52%	-54.94%
LONG-TERM LIABILITIES
Long-Term Debt	$463.4K	$470.8K	$500.0K
YoY Change	-7.31%	-5.85%	0.0%
Other Long-Term Liabilities		$0.00	$0.00
YoY Change
Total Long-Term Liabilities	$463.4K	$470.8K	$500.0K
YoY Change	-7.31%	-5.85%	0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.512M	$2.510M	$3.007M
Total Long-Term Liabilities	$463.4K	$470.8K	$500.0K
Total Liabilities	$2.976M	$2.981M	$3.507M
YoY Change	-7.86%	-15.0%	-51.11%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.05M	-$24.83M	-$24.06M
YoY Change	4.55%	3.22%	10.13%
Common Stock	$99.43K	$99.43K	$94.61K
YoY Change	0.66%	5.09%	4.73%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$1.725M	-$1.591M	-$1.472M
YoY Change
Total Liabilities & Shareholders Equity	$1.251M	$1.390M	$2.035M
YoY Change	-36.44%	-31.71%	-34.92%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$220.0K	-$398.6K	-$210.0K
YoY Change	-330.63%	89.83%	-107.1%
Depreciation, Depletion And Amortization	$182.2K	$180.0K	$181.1K
YoY Change	0.61%	-0.61%	0.0%
Cash From Operating Activities	$60.58K	-$185.5K	-$33.59K
YoY Change	-45.04%	452.17%	-71.16%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-29.62K	-$57.31K	-$108.3K
YoY Change	-20.61%	-47.1%
NET CHANGE
Cash From Operating Activities	60.58K	-$185.5K	-$33.59K
Cash From Investing Activities	0.000	$0.00	$0.00
Cash From Financing Activities	-29.62K	-$57.31K	-$108.3K
Net Change In Cash	30.96K	-$242.8K	-$141.9K
YoY Change	-57.54%	71.07%	21.83%
FREE CASH FLOW
Cash From Operating Activities	$60.58K	-$185.5K	-$33.59K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1225034	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	635136	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-361009	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-158991	usd
CY2023Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001643721
CY2023Q3	dei	Amendment Flag AmendmentFlag	false
CY2023Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99428575	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	99428575	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	dei	Document Type DocumentType	10-Q
CY2023Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q3	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
CY2023Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q3	dei	Entity File Number EntityFileNumber	333-206745
CY2023Q3	dei	Entity Registrant Name EntityRegistrantName	LEAFBUYER TECHNOLOGIES, INC.
CY2023Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	38-3944821
CY2023Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	6888 S. Clinton Street
CY2023Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2023Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Greenwood Village
CY2023Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2023Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80112
CY2023Q3	dei	City Area Code CityAreaCode	720
CY2023Q3	dei	Local Phone Number LocalPhoneNumber	235-0099
CY2023Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023Q3	dei	Entity Ex Transition Period EntityExTransitionPeriod	true
CY2023Q3	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	99428575	shares
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	202931	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	445721	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	49982	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	14037	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	127200	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	135476	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	15732	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	29268	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	345863	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	610465	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1043922	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1225034	usd
CY2023Q3	us-gaap	Assets Assets	1389785	usd
CY2023Q2	us-gaap	Assets Assets	1835499	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	312053	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	308840	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1089327	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1165815	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	7012	usd
CY2023Q2	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	10029	usd
CY2023Q3	lbuy	Due To Related Party Current DueToRelatedPartyCurrent	107817	usd
CY2023Q2	lbuy	Due To Related Party Current DueToRelatedPartyCurrent	107817	usd
CY2023Q3	us-gaap	Debt Current DebtCurrent	993802	usd
CY2023Q2	us-gaap	Debt Current DebtCurrent	1036491	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	2510011	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2628992	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	470756	usd
CY2023Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	485378	usd
CY2023Q3	us-gaap	Liabilities Liabilities	2980767	usd
CY2023Q2	us-gaap	Liabilities Liabilities	3114370	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99428575	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	99428575	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	99428	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	99428	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23143554	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23057067	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24834296	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24435698	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-1590982	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1278871	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1389785	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1835499	usd
CY2023Q3	us-gaap	Revenues Revenues	1169622	usd
CY2022Q3	us-gaap	Revenues Revenues	1128665	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	813344	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	652520	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	356278	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	476145	usd
CY2023Q3	us-gaap	Selling Expense SellingExpense	196371	usd
CY2022Q3	us-gaap	Selling Expense SellingExpense	161314	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	249504	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	163163	usd
CY2023Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	184926	usd
CY2022Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	188210	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	86486	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	122449	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	717287	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	37624	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	51027	usd
CY2023Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	usd
CY2022Q3	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	usd
CY2023Q3	lbuy	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	0	usd
CY2022Q3	lbuy	Forgiveness Of Ppp Loan ForgivenessOfPppLoan	0	usd
CY2023Q3	us-gaap	Other Income OtherIncome	35	usd
CY2022Q3	us-gaap	Other Income OtherIncome	46	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-398598	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-209972	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	99428575	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	94040463	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	151137140	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	145749028	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-1412547	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	88211	usd
CY2022Q3	lbuy	Stock Issued During Period Value Issued For Vendor Payments StockIssuedDuringPeriodValueIssuedForVendorPayments	28500	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	34238	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-209972	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-1471572	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-1278871	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions	86487	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-398598	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-1590982	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-398598	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-209972	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	86487	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	122449	usd
CY2023Q3	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	0	usd
CY2022Q3	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	28500	usd
CY2023Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2022Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	0	usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	0	usd
CY2023Q3	lbuy	Forgiveness Of Ppp Loans ForgivenessOfPppLoans	0	usd
CY2022Q3	lbuy	Forgiveness Of Ppp Loans ForgivenessOfPppLoans	0	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	181112	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	181111	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8276	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2488	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	13536	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8376	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3213	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-42048	usd
CY2023Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-79505	usd
CY2022Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-124495	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-185479	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33591	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023Q3	us-gaap	Repayments Of Debt RepaymentsOfDebt	57311	usd
CY2022Q3	us-gaap	Repayments Of Debt RepaymentsOfDebt	108333	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-57311	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-108333	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-242790	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-141924	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	445721	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	367245	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	202931	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	225321	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2022Q3	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q3	lbuy	Issuance Of Common Stock For Vendor Payments IssuanceOfCommonStockForVendorPayments	0	usd
CY2022Q3	lbuy	Issuance Of Common Stock For Vendor Payments IssuanceOfCommonStockForVendorPayments	28500	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	202931	usd
CY2023Q3	lbuy	Working Capital Deficit WorkingCapitalDeficit	-2164148	usd
CY2023Q3	lbuy	Retained Earning Accumulated Deficit RetainedEarningAccumulatedDeficit	-24435698	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-398598	usd
CY2023Q3	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Management uses estimates and assumptions in preparing these condensed consolidated financial statements. Those estimates and assumptions affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities, and the reported revenues and expenses. Examples of estimates include loss contingencies; useful lives of our tangible and intangible assets; allowances for doubtful accounts; and stock-based compensation forfeiture rates. Examples of assumptions include: the elements comprising a software arrangement, including the distinction between upgrades or enhancements and new products; when technological feasibility is achieved for our products; the potential outcome of future tax consequences of events that have been recognized in our financial statements or tax returns. Actual results could differ from those estimates.</p>
CY2023Q3	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain prior period amounts have been reclassified to conform with the current period presentation.</p>
CY2023Q3	lbuy	Finite Lived Intangible Assets Software Platform FiniteLivedIntangibleAssetsSoftwarePlatform	4482225	usd
CY2023Q2	lbuy	Finite Lived Intangible Assets Software Platform FiniteLivedIntangibleAssetsSoftwarePlatform	4482225	usd
CY2023Q3	lbuy	Finite Lived Intangible Assets Furniture And Fixtures FiniteLivedIntangibleAssetsFurnitureAndFixtures	1500	usd
CY2023Q2	lbuy	Finite Lived Intangible Assets Furniture And Fixtures FiniteLivedIntangibleAssetsFurnitureAndFixtures	1500	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-3438302	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-3258691	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1043922	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	181112	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	181111	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	724445	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	319478	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1043922	usd
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	700000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q3	lbuy	Articles Of Amendment ArticlesOfAmendment	the Company filed Articles of Amendment to Amended and Restated Articles of Incorporation with the State of Nevada increasing the number of common shares from 150,000,000 to 700,000,000
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019	lbuy	Amortization Of Beneficial Conversion Feature AmortizationOfBeneficialConversionFeature	801741	usd
CY2019	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	533000	usd
CY2019	us-gaap	Repayments Of Debt RepaymentsOfDebt	402000	usd
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	131000	usd
CY2019	lbuy	Remaining Principal Amount RemainingPrincipalAmount	90125	usd
CY2019Q2	lbuy	Total Unpaid Principal Balance TotalUnpaidPrincipalBalance	376657	usd
CY2020Q2	lbuy	Edil Loan Amount EDILLoanAmount	500000	usd
CY2023Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	37624	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	51027	usd
CY2023Q3	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	746980	usd
CY2022Q3	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	603639	usd
CY2023Q3	lbuy	Weighted Average Interest Rate WeightedAverageInterestRate	0.0549	pure
CY2022Q3	lbuy	Weighted Average Interest Rate WeightedAverageInterestRate	0.0647	pure
CY2023Q3	lbuy	Notes Payable Non Current Portion NotesPayableNonCurrentPortion	470756	usd
CY2023Q2	lbuy	Notes Payable Non Current Portion NotesPayableNonCurrentPortion	478067	usd
CY2023Q3	us-gaap	Notes Payable NotesPayable	1572375	usd
CY2023Q2	us-gaap	Notes Payable NotesPayable	1629686	usd
CY2023Q3	lbuy	Less Current Portion Of Notes Payable LessCurrentPortionOfNotesPayable	1101619	usd
CY2023Q2	lbuy	Less Current Portion Of Notes Payable LessCurrentPortionOfNotesPayable	1144108	usd
CY2023Q3	lbuy	Options Nonvested Beginning Balance OptionsNonvestedBeginningBalance	662608	shares
CY2023Q3	lbuy	Weighted Average Grant Date Fair Falue Nonvested Beginning WeightedAverageGrantDateFairFalueNonvestedBeginning	0.11
CY2023Q3	lbuy	Options Granted OptionsGranted	0	shares
CY2023Q3	lbuy	Weighted Average Grant Date Fair Falue Granted WeightedAverageGrantDateFairFalueGranted	0.00
CY2023Q3	lbuy	Options Vested OptionsVested	0	usd
CY2023Q3	lbuy	Weighted Average Grant Date Fair Falue Vested WeightedAverageGrantDateFairFalueVested	0.00
CY2023Q3	lbuy	Weighted Average Grant Date Fair Falue Forfeited WeightedAverageGrantDateFairFalueForfeited	0.00
CY2023Q3	lbuy	Options Nonvested Ending Balance OptionsNonvestedEndingBalance	662608	shares
CY2023Q3	lbuy	Weighted Average Grant Date Fair Falue Nonvested Ending WeightedAverageGrantDateFairFalueNonvestedEnding	0.11
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	28072364	shares
CY2023Q3	lbuy	Aggregate Intrinsic Value AggregateIntrinsicValue	0	usd
CY2023Q3	lbuy	Lessee Operating Lease Term Period LesseeOperatingLeaseTermPeriod	P12M
CY2023Q3	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The Company will recognize lease expense on a monthly basis through the life of this lease
CY2023Q3	us-gaap	Operating Lease Initial Direct Cost Expense Over Term OperatingLeaseInitialDirectCostExpenseOverTerm	51786	usd

Files In Submission

Name	View Source	Status
0001477932-23-008496-index-headers.html	Edgar Link	pending
0001477932-23-008496-index.html	Edgar Link	pending
0001477932-23-008496.txt	Edgar Link	pending
0001477932-23-008496-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
lbuy-20230930.xsd	Edgar Link	pending
lbuy_10q.htm	Edgar Link	pending
lbuy_ex311.htm	Edgar Link	pending
lbuy_ex312.htm	Edgar Link	pending
lbuy_ex321.htm	Edgar Link	pending
lbuy_ex322.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
lbuy-20230930_lab.xml	Edgar Link	unprocessable
lbuy-20230930_cal.xml	Edgar Link	unprocessable
lbuy-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
lbuy-20230930_def.xml	Edgar Link	unprocessable
lbuy_10q_htm.xml	Edgar Link	completed
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LBUY
LEAFBUYER TECHNOLOGIES, INC. Stock $lbuy

2023 Q4 Form 10-Q Financial Statement

#000147793223008496 Filed on November 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LBUY LEAFBUYER TECHNOLOGIES, INC. Stock $lbuy

2023 Q4 Form 10-Q Financial Statement

#000147793223008496 Filed on November 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LBUY
LEAFBUYER TECHNOLOGIES, INC. Stock $lbuy